Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Adult Immune Responses to Vaccine”

196 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 196 results

Early research (Phase 1)Study completedNCT00384787
What this trial is testing

Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT00858611
What this trial is testing

VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...

Who this might be right for
Influenza, Human
National Institute of Allergy and Infectious Diseases (NIAID) 51
Testing effectiveness (Phase 2)Study completedNCT01511250
What this trial is testing

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Who this might be right for
Healthy
Takeda 360
Not applicableEnded earlyNCT01673425
What this trial is testing

Evaluating Immune Response to Seasonal FluMist in Healthy Adults

Who this might be right for
Influenza
National Center for Occupational Health and Infection Control 5
Testing effectiveness (Phase 2)Study completedNCT05480800
What this trial is testing

Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever

Who this might be right for
Salmonella Infections
GlaxoSmithKline 155
Early research (Phase 1)UnknownNCT05231369
What this trial is testing

Safety and Immunogenicity of ChulaCov19 BNA159 mRNA Vaccine

Who this might be right for
Safety of 25 ug of ChulaCov19-BNA159 mRNA VaccineTolerability of 25 ug of ChulaCov19-BNA159 mRNA VaccineImmune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine+4 more
Chulalongkorn University 24
Early research (Phase 1)Study completedNCT05613205
What this trial is testing

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Who this might be right for
Typhoid Fever
GlaxoSmithKline 97
Testing effectiveness (Phase 2)Study completedNCT03746015
What this trial is testing

Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults

Who this might be right for
Dengue Fever
Takeda 30
Early research (Phase 1)Study completedNCT02564575
What this trial is testing

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT01578889
What this trial is testing

Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Study completedNCT00366782
What this trial is testing

Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 51
Large-scale testing (Phase 3)Study completedNCT04084769
What this trial is testing

Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

Who this might be right for
Meningococcal Immunisation (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 570
Testing effectiveness (Phase 2)Study completedNCT00192309
What this trial is testing

Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.

Who this might be right for
Influenza
MedImmune LLC 31
Early research (Phase 1)Study completedNCT04495933
What this trial is testing

A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults

Who this might be right for
SARS-CoV2Covid19
The University of Queensland 216
Early research (Phase 1)Study completedNCT03186781
What this trial is testing

Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT06069544
What this trial is testing

A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria

Who this might be right for
Malaria
BioNTech SE 163
Early research (Phase 1)Study completedNCT00054860
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Not applicableStudy completedNCT02032160
What this trial is testing

Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines

Who this might be right for
Hepatitis B
University of Surrey 30
Early research (Phase 1)Study completedNCT03478891
What this trial is testing

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 19
Early research (Phase 1)Study completedNCT02996461
What this trial is testing

VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy Adults

Who this might be right for
Prevention of Zika InfectionZika-Specific Immune Response
National Institute of Allergy and Infectious Diseases (NIAID) 45
Load More Results